Understand the source comparison
Cartalax Interactions: Research Peptide Combinations Comparison
Growth Hormone Secretagogues Ipamorelin, CJC-1295, Hexarelin IGF-1 elevation supports collagen synthesis; complementary anabolic pathways High. Additive cartilage repair effects Concurrent dosing within 30-60 min window Strong synergy documented; conservative
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Growth Hormone Secretagogues
- Ipamorelin, CJC-1295, Hexarelin
- IGF-1 elevation supports collagen synthesis; complementary anabolic pathways
- High. Additive cartilage repair effects
- Concurrent dosing within 30-60 min window
- Strong synergy documented; conservative GH dosing optimal
- Immune Modulators
- Thymosin Alpha-1, KPV, BPC-157
- Reduces inflammatory cytokines that suppress chondrocyte function
- High. Addresses inflammation and repair simultaneously
- Concurrent or sequential (immune first in acute models)
- Genuine synergy observed; reduces MMP activity
- AMPK Activators
- MOTS-c, 5-Amino-1MQ
- AMPK inhibits mTOR; potential antagonism to anabolic collagen synthesis
- Low to moderate. Context-dependent
- Temporal separation (metabolic AM, Cartalax PM)
- Theoretical antagonism; minimal data; separate dosing safer
- GLP-1 Agonists
- Tirzepatide, Semaglutide
- Systemic metabolic improvement; no direct pathway conflict
- Moderate. Indirect cartilage benefit via weight loss
- No timing restriction
- Complementary in obesity models; no mechanistic antagonism
- Tissue Repair Peptides
- TB-500, BPC-157
- Overlapping extracellular matrix and collagen signaling
- Moderate. Some redundancy possible
- Concurrent dosing acceptable
- Additive rather than synergistic; consider dosing reduction
- Cognitive Peptides
- Semax, Selank, Cerebrolysin
- No direct mechanistic interaction with cartilage pathways
- Neutral. No expected interaction
- Safe to combine; orthogonal mechanisms